CRSP icon

CRISPR Therapeutics

35 hedge funds and large institutions have $211M invested in CRISPR Therapeutics in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+9
Holders Change %
+34.62%
% of All Funds
0.87%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
18
Increased
5
Reduced
3
Closed
9
Calls
Puts
Net Calls
Net Calls Change